VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 6, 2009, Pages 1977-1982

  Argaw, Azeb Tadesse ^a   Gurfein, Blake T ^a   Zhang, Yueting ^a   Zameer, Andleeb ^a   John, Gareth R ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CNS; Cytokine; Inflammation; Tight junction

Indexed keywords

VASCULOTROPIN A;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL;

ANIMALS; BLOOD-BRAIN BARRIER; CATTLE; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MEMBRANE PROTEINS; MICE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA;

EID: 60649108674     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0808698106     Document Type: Article

References (40)

1. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178-201.
2. Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41-53.
3. Tsukita S, Furuse M (2002) Claudin-based barrier in simple and stratified cellular sheets. Curr Opin Cell Biol 14:531-536.
4. Morita K, Sasaki H, Furuse M, Tsukita S (1999) Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147:185-194.
5. Ohtsuki S, et al. (2007) Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells. J Cell Physiol 210:81-86.
6. Nitta T,, et al. (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161:653-660.
7. Furuse M, et al. (1993) Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123:1777-1788.
8. Saitou M, et al. (1998) Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 141:397-408.
9. Saitou M, et al. (2000) Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11:4131-4142.
10. Janzer RC, Raff MC (1987) Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325:253-257.
11. Lindahl P, Johansson BR, Levéen P, Betsholtz C (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242-245.
12. Tallquist MD, French WJ, Soriano P (2003) Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development. PLoS Biol 1:E52.
13. Bunge RP, Bunge MB, Ris H (1960) Electron microscopic study of demyelination in an experimentally induced lesion in adult cat spinal cord. J Biophys Biochem Cytol 7:685-696.
14. Schachtrup C, et al. (2007) Fibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptor. Proc Natl Acad Sci USA 104:11814-11819.
15. Bush TG, et al. (1999) Leukocyte infiltration, neuronal degeneration, and neurite out-growth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23:297-308.
16. Argaw AT, et al. (2006) Interleukin-1β induces blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 177:5574-5584.
17. Carmeliet P, et al.. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
18. Ferrara N, etal. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
19. Dobrogowska DH, Lossinsky AS, Tarnawski M, Vorbrodt AW (1998) Increased blood- brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol 27:163-173.
20. Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ (2002) Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 61:914-925.
21. Chen L, Brosnan CF (2006) Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes. J Immunol 176:3115-3126.
22. Kristensson K, Wiśniewski HM (1977) Chronic relapsing experimental allergic encephalomyelitis. Studies in vascular permeability changes. Acta Neuropathol 39:189-194.
23. Song L, Ge S, Pachter JS (2007) Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood 109:1515-1523.
24. Conn G, et al. (1990) Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87:2628-2632.
25. Polette M, et al. (2005) Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Cancer Res 65:7691-7698.
26. Shalaby F, et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
27. Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70.
28. Jin KL, Mao XO, Greenberg DA (2000) Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 97:10242-10247.
29. Storkebaum E, et al. (2005) Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8:85-92.
30. Reichenbach A, Wolburg H (2004) Astrocytes and ependymal glia. Neuroglia, eds Kettemann H, Ransom BR (Oxford Univ. Press, New York), 2nd Ed, pp 19-35.
31. Liebner S, et al. (2000) Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol 100:323-331.
32. Zhong Z, etal. (2008) ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 11:420-422.
33. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S (1997) Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 137:1393-1401.
34. Hirase T, et al. (2001) Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms. J Biol Chem 276:10423-10431.
35. Balda MS, Flores-Maldonado C, Cereijido M, Matter K (2000) Multiple domains of occludin are involved in the regulation of paracellular permeability. J Cell Biochem 78:85-96.
36. Lacaz-Vieira F, Jaeger MM, Farshori P, Kachar B. Small synthetic peptides homologous to segments of the first external loop of occludin impair tight junction resealing. J Membr Biol 168:289-297.
37. Morgan L, et al. (2007) Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis. Neuroscience 147:664-673.
38. Kebir, et al. (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13:1173-1175.
39. Burek M, Förster CY (2008) Cloning and characterization of the murine claudin-5 promoter. Mol Cell Endocrinol, in press.
40. Matsuda M, Kubo A, Furuse M, Tsukita S (2004) A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movementof epithelial cells. J Cell Sci 117:1247-1257.